argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
842.00
0.00 (0.00%)
At close: Jan 28, 2026
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$2,303,490
Profits / Employee
$958,878
Market Cap
51.87B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 150 | 80.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
argenx SE News
- 7 days ago - Prime Capital Investment Advisors, LLC Buys 266 Shares of argenx SE (ARGX) - GuruFocus
- 8 days ago - Independence Bank of Kentucky Buys 2 Shares of argenx SE (ARGX) - GuruFocus
- 9 days ago - ARGX: Wells Fargo Raises Price Target to $1317, Maintains Overweight Rating | ARGX Stock News - GuruFocus
- 9 days ago - Artisan Mid Cap Fund Q4 2025 Performance Discussion And Portfolio Activity - Seeking Alpha
- 15 days ago - Wedbush Reiterates Outperform Rating for ARGX with $1000 PT | ARGX Stock News - GuruFocus
- 16 days ago - Argenx (ARGX) Gains FDA Priority Review for Expanded Vyvgart Use - GuruFocus
- 16 days ago - Argenx bid for Vyvgart label expansion undergoes FDA priority review - Seeking Alpha
- 16 days ago - FDA Prioritizes Argenx's sBLA for Vyvgart in Myasthenia Gravis Treatment - GuruFocus